RESUMEN
BACKGROUND: Age-related neurodegenerative diseases are constantly increasing with prediction that in 2050 over 60 % of population will suffer from some level of cognitive impairment. A cure for the Alzheimer's disease (AD) does not exist, so early diagnosis is of a great importance. Machine learning techniques can help in early diagnosis with deep medical data processing, disease understanding, intervention analysis and knowledge discovery for achieving better medical decision making. METHODS: In this paper, we analyze the dataset consisting of 90 individuals and 482 input features. We investigate the achieved AD prediction performances using seven classifiers and five feature selection algorithms. We pay special focus on analyzing performance by utilizing only a subset of best ranked attributes to establish the minimum amount of input features that ensure acceptable performance. We also investigate the significance of neuropsychological (NP) and neuroradiological (NR) attributes for the AD diagnosis. RESULTS: The accuracy for the whole set of attributes ranged between 66.22 % and 81.00 %, and the weighted average AUROC was between 76.3 % and 95.0 %. The best results were achieved by the naive Bayes classifier and the Relief feature selection algorithm. Additionally, Support Vector Machines classifier shows the most stable results since it depends the least on the feature selection algorithm which is used. As the main result of this paper, we compare the performance of models trained with automatically selected features to models trained with hand-selected features performed by medical experts (NP and NR features). CONCLUSIONS: The results reveal that unlike the NR attributes, the NP attributes achieve a good performance that is comparable to the full set of attributes, which suggests that they possess a high predictive power for AD diagnosis.
RESUMEN
Machine learning and data mining approaches are being successfully applied to different fields of life sciences for the past 20 years. Medicine is one of the most suitable application domains for these techniques since they help model diagnostic information based on causal and/or statistical data and therefore reveal hidden dependencies between symptoms and illnesses. In this paper we give a detailed overview of the recent machine learning research and its applications for predicting cognitive diseases, especially the Alzheimer's disease, mild cognitive impairment and the Parkinson's disease. We survey different state-of-the-art methodological approaches, data sources and public data, and provide their comparative analysis. We conclude by identifying the open problems within the field that include an early detection of the cognitive diseases and inclusion of machine learning tools into diagnostic practice and therapy planning.
Asunto(s)
Enfermedad de Alzheimer/epidemiología , Trastornos del Conocimiento/epidemiología , Aprendizaje Automático , Enfermedad de Parkinson/epidemiología , Algoritmos , Enfermedad de Alzheimer/diagnóstico , Trastornos del Conocimiento/diagnóstico , Diagnóstico por Imagen , Diagnóstico Precoz , Electroencefalografía , Pruebas Hematológicas , Humanos , Enfermedad de Parkinson/diagnóstico , Factores de RiesgoRESUMEN
There exists a major concern regarding toxic effects of immunosuppressive medication on the kidney graft during post-transplant care, with observed variation in individual susceptibility to adverse drug effects amongst patients. To date, there has been no possibility to identify susceptible patients prospectively. This study analyzes medical data which includes time series of measures of renal function and trough levels of immunosuppressive drug Tacrolimus, with the main aim of identifying patients susceptible to drug toxicity. We evaluate a plethora of time-series distance measures, determining their appropriateness to the domain based on two criteria: (1) preserving the expected correlations between distances, and (2) ability to detect the expected patterns of interaction between immunosuppressive drug levels and renal function. Besides identifying the most suitable time-series distance measures, we observed that the majority of patients do not exhibit an association between impaired graft function and higher Tacrolimus dosing. On the other hand, the minority of patients determined most sensitive to varying Tacrolimus levels showed a strong tendency to prefer low Tacrolimus dosing.